The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nanobiotechnology-Global Market Insights and Sales Trends 2024
Synopsis
Nanobiotechnology is a veritable tool for the advancement of medical science, which will help improve healthcare practices across the world. This is because nanobiotechnology is the key for studying minute biological samples as small as a single molecule. The use of several nanoparticles and nanodevices for studying small biological samples are expected to benefit human health enormously. The use of nanobiotechnology is expected to extend opportunities and enhance the capabilities of other areas such as forensic science and forensic diagnostics.
The global Nanobiotechnology market size is expected to reach US$ 103260 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Nanobiotechnology in various end use industries. The expanding demands from the Anticancer, CNS Product, Anti-infective and Other, are propelling Nanobiotechnology market. Nanomedicine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nano Medical Devices segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nanobiotechnology market, driven by demand from China, the second largest economy with some signs of stabilising, the Nanobiotechnology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanobiotechnology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanobiotechnology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanobiotechnology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanobiotechnology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanobiotechnology covered in this report include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc.
The global Nanobiotechnology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Global Nanobiotechnology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanobiotechnology market, Segment by Type:
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Global Nanobiotechnology market, by Application
Anticancer
CNS Product
Anti-infective
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanobiotechnology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Nanobiotechnology is a veritable tool for the advancement of medical science, which will help improve healthcare practices across the world. This is because nanobiotechnology is the key for studying minute biological samples as small as a single molecule. The use of several nanoparticles and nanodevices for studying small biological samples are expected to benefit human health enormously. The use of nanobiotechnology is expected to extend opportunities and enhance the capabilities of other areas such as forensic science and forensic diagnostics.
The global Nanobiotechnology market size is expected to reach US$ 103260 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Nanobiotechnology in various end use industries. The expanding demands from the Anticancer, CNS Product, Anti-infective and Other, are propelling Nanobiotechnology market. Nanomedicine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nano Medical Devices segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nanobiotechnology market, driven by demand from China, the second largest economy with some signs of stabilising, the Nanobiotechnology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanobiotechnology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanobiotechnology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanobiotechnology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanobiotechnology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanobiotechnology covered in this report include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc.
The global Nanobiotechnology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Global Nanobiotechnology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanobiotechnology market, Segment by Type:
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Global Nanobiotechnology market, by Application
Anticancer
CNS Product
Anti-infective
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanobiotechnology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nanobiotechnology
1.1 Nanobiotechnology Market Overview
1.1.1 Nanobiotechnology Product Scope
1.1.2 Nanobiotechnology Market Status and Outlook
1.2 Global Nanobiotechnology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nanobiotechnology Market Size by Region (2018-2029)
1.4 Global Nanobiotechnology Historic Market Size by Region (2018-2023)
1.5 Global Nanobiotechnology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nanobiotechnology Market Size (2018-2029)
1.6.1 North America Nanobiotechnology Market Size (2018-2029)
1.6.2 Europe Nanobiotechnology Market Size (2018-2029)
1.6.3 Asia-Pacific Nanobiotechnology Market Size (2018-2029)
1.6.4 Latin America Nanobiotechnology Market Size (2018-2029)
1.6.5 Middle East & Africa Nanobiotechnology Market Size (2018-2029)
2 Nanobiotechnology Market by Type
2.1 Introduction
2.1.1 Nanomedicine
2.1.2 Nano Medical Devices
2.1.3 Nano Diagnosis
2.1.4 Other
2.2 Global Nanobiotechnology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nanobiotechnology Historic Market Size by Type (2018-2023)
2.2.2 Global Nanobiotechnology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nanobiotechnology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nanobiotechnology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nanobiotechnology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nanobiotechnology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nanobiotechnology Revenue Breakdown by Type (2018-2029)
3 Nanobiotechnology Market Overview by Application
3.1 Introduction
3.1.1 Anticancer
3.1.2 CNS Product
3.1.3 Anti-infective
3.1.4 Other
3.2 Global Nanobiotechnology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nanobiotechnology Historic Market Size by Application (2018-2023)
3.2.2 Global Nanobiotechnology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nanobiotechnology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nanobiotechnology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nanobiotechnology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nanobiotechnology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nanobiotechnology Revenue Breakdown by Application (2018-2029)
4 Nanobiotechnology Competition Analysis by Players
4.1 Global Nanobiotechnology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2022)
4.3 Date of Key Players Enter into Nanobiotechnology Market
4.4 Global Top Players Nanobiotechnology Headquarters and Area Served
4.5 Key Players Nanobiotechnology Product Solution and Service
4.6 Competitive Status
4.6.1 Nanobiotechnology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen
5.1.1 Amgen Profile
5.1.2 Amgen Main Business
5.1.3 Amgen Nanobiotechnology Products, Services and Solutions
5.1.4 Amgen Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.1.5 Amgen Recent Developments
5.2 Teva Pharmaceuticals
5.2.1 Teva Pharmaceuticals Profile
5.2.2 Teva Pharmaceuticals Main Business
5.2.3 Teva Pharmaceuticals Nanobiotechnology Products, Services and Solutions
5.2.4 Teva Pharmaceuticals Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Pharmaceuticals Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Nanobiotechnology Products, Services and Solutions
5.3.4 Abbott Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.3.5 UCB Recent Developments
5.4 UCB
5.4.1 UCB Profile
5.4.2 UCB Main Business
5.4.3 UCB Nanobiotechnology Products, Services and Solutions
5.4.4 UCB Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.4.5 UCB Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Nanobiotechnology Products, Services and Solutions
5.5.4 Roche Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Celgene
5.6.1 Celgene Profile
5.6.2 Celgene Main Business
5.6.3 Celgene Nanobiotechnology Products, Services and Solutions
5.6.4 Celgene Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.6.5 Celgene Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Nanobiotechnology Products, Services and Solutions
5.7.4 Sanofi Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
5.8 Merck & Co
5.8.1 Merck & Co Profile
5.8.2 Merck & Co Main Business
5.8.3 Merck & Co Nanobiotechnology Products, Services and Solutions
5.8.4 Merck & Co Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.8.5 Merck & Co Recent Developments
5.9 Biogen
5.9.1 Biogen Profile
5.9.2 Biogen Main Business
5.9.3 Biogen Nanobiotechnology Products, Services and Solutions
5.9.4 Biogen Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.9.5 Biogen Recent Developments
5.10 Stryker
5.10.1 Stryker Profile
5.10.2 Stryker Main Business
5.10.3 Stryker Nanobiotechnology Products, Services and Solutions
5.10.4 Stryker Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.10.5 Stryker Recent Developments
5.11 Gilead Sciences
5.11.1 Gilead Sciences Profile
5.11.2 Gilead Sciences Main Business
5.11.3 Gilead Sciences Nanobiotechnology Products, Services and Solutions
5.11.4 Gilead Sciences Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.11.5 Gilead Sciences Recent Developments
5.12 Pfizer
5.12.1 Pfizer Profile
5.12.2 Pfizer Main Business
5.12.3 Pfizer Nanobiotechnology Products, Services and Solutions
5.12.4 Pfizer Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.12.5 Pfizer Recent Developments
5.13 3M Company
5.13.1 3M Company Profile
5.13.2 3M Company Main Business
5.13.3 3M Company Nanobiotechnology Products, Services and Solutions
5.13.4 3M Company Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.13.5 3M Company Recent Developments
5.14 Johnson & Johnson
5.14.1 Johnson & Johnson Profile
5.14.2 Johnson & Johnson Main Business
5.14.3 Johnson & Johnson Nanobiotechnology Products, Services and Solutions
5.14.4 Johnson & Johnson Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.14.5 Johnson & Johnson Recent Developments
5.15 Smith & Nephew
5.15.1 Smith & Nephew Profile
5.15.2 Smith & Nephew Main Business
5.15.3 Smith & Nephew Nanobiotechnology Products, Services and Solutions
5.15.4 Smith & Nephew Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.15.5 Smith & Nephew Recent Developments
5.16 Leadiant Biosciences
5.16.1 Leadiant Biosciences Profile
5.16.2 Leadiant Biosciences Main Business
5.16.3 Leadiant Biosciences Nanobiotechnology Products, Services and Solutions
5.16.4 Leadiant Biosciences Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.16.5 Leadiant Biosciences Recent Developments
5.17 Kyowa Hakko Kirin
5.17.1 Kyowa Hakko Kirin Profile
5.17.2 Kyowa Hakko Kirin Main Business
5.17.3 Kyowa Hakko Kirin Nanobiotechnology Products, Services and Solutions
5.17.4 Kyowa Hakko Kirin Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.17.5 Kyowa Hakko Kirin Recent Developments
5.18 Shire
5.18.1 Shire Profile
5.18.2 Shire Main Business
5.18.3 Shire Nanobiotechnology Products, Services and Solutions
5.18.4 Shire Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.18.5 Shire Recent Developments
5.19 Ipsen
5.19.1 Ipsen Profile
5.19.2 Ipsen Main Business
5.19.3 Ipsen Nanobiotechnology Products, Services and Solutions
5.19.4 Ipsen Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.19.5 Ipsen Recent Developments
5.20 Endo International
5.20.1 Endo International Profile
5.20.2 Endo International Main Business
5.20.3 Endo International Nanobiotechnology Products, Services and Solutions
5.20.4 Endo International Nanobiotechnology Revenue (US$ Million) & (2018-2023)
5.20.5 Endo International Recent Developments
6 North America
6.1 North America Nanobiotechnology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nanobiotechnology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nanobiotechnology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nanobiotechnology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nanobiotechnology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nanobiotechnology Market Dynamics
11.1 Nanobiotechnology Industry Trends
11.2 Nanobiotechnology Market Drivers
11.3 Nanobiotechnology Market Challenges
11.4 Nanobiotechnology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
